BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 4128917)

  • 21. [Initial results of cytostatic therapy of squamous cell carcinoma of the oral cavity using a combination of methotrexate and bleomycin].
    Bitter K
    Dtsch Zahn Mund Kieferheilkd Zentralbl Gesamte; 1973 Feb; 60(2):81-93. PubMed ID: 4122694
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term results of the treatment of advanced oral mucosal carcinoma with vincristine, methotrexate, bleomycin and nucleoside rescue. A report of over 242 cases].
    Singer R; Weidauer H; Edler L; Osswald H
    Dtsch Z Mund Kiefer Gesichtschir; 1984; 8(4):264-70. PubMed ID: 6084570
    [No Abstract]   [Full Text] [Related]  

  • 23. [Induction chemotherapy in cancer of the upper respiratory and digestive tract. Preliminary results of the protocol combining cisplatin, 5-fluorouracil and bleomycin (CFB)].
    Laccourreye H; Bassot V; Lacau St Guily J; Brasnu D; Menard M; Donnadieu S; Jacquillat C
    Ann Otolaryngol Chir Cervicofac; 1985; 102(1):1-6. PubMed ID: 2408533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Carcinoma of the upper respiratory and digestive tracts. Histopathology and chemotherapy in 300 cases (author's transl)].
    Jaubert F; Dulmet-Brender E; Beutter P; Brasnu D; Renault P
    Ann Otolaryngol Chir Cervicofac; 1981; 98(9):431-4. PubMed ID: 6176170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidermoid carcinoma of the oropharyngeolaryngeal region. Overview and chemotherapy].
    Medenica R
    Med Hyg (Geneve); 1979 Oct; 37(1348):3232-41. PubMed ID: 297193
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined regional chemotherapy and radiation therapy in the treatment of epidermoid carcinoma in the oro-facial region.
    Danko J; Satko I; Durkovský J
    Neoplasma; 1979; 26(3):345-50. PubMed ID: 93709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antineoplastic agent bleomycin in malignancies of the otorhinolaryngologic region].
    Baumberger K
    Schweiz Med Wochenschr; 1973 Feb; 103(6):212-6. PubMed ID: 4119628
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neck.
    Donegan WL; Harris HS
    Am J Surg; 1972 May; 123(5):549-59. PubMed ID: 4112554
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen.
    Elias EG; Chretien PB; Monnard E; Khan T; Bouchelle WH; Wiernik PH; Lipson SD; Hande KR; Zentai T
    Cancer; 1979 Mar; 43(3):1025-31. PubMed ID: 85477
    [No Abstract]   [Full Text] [Related]  

  • 30. Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program.
    Lane M; Moore JE; Levin H; Smith FE
    JAMA; 1968 May; 204(7):561-4. PubMed ID: 5694477
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum.
    Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A
    Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination CCNU and bleomycin therapy for squamous cell carcinoma.
    Lindell TD; Moseley HS; Fletcher WS
    Am Surg; 1974 May; 40(5):281-9. PubMed ID: 4132376
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antineoplastic chemotherapy of head and neck tumors (author's transl)].
    Weidauer H
    HNO; 1981 Nov; 29(11):374-80. PubMed ID: 6171551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy of cancers of the larynx and hypopharynx].
    Leroux-Robert J
    Acta Otorhinolaryngol Belg; 1973; 27(7):883-96. PubMed ID: 4129940
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenously-administered methotrexate and radiotherapy in the treatment of advanced lesions of the oral cavity and the pharynx.
    Perez-Tamayo R; Alcancia E; Soberon M
    Mo Med; 1969 Dec; 66(12):943-6. PubMed ID: 5353693
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharyngolaryngeal cancers treated with bleomycin. Histopathological assessment].
    Renault P; André P; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1972; 89(4):229-38. PubMed ID: 4116542
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intra-arterial chemotherapy of head and neck tumors: statistical study of 129 cases treated at the Institut Gustave Roussy].
    Richard JM; Sancho H
    Biomedicine; 1973 Sep; 18(5):429-35. PubMed ID: 4127613
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tumor and lymph node response to chemotherapy. Prognosis in cancer of the pyriform sinus and the lateral laryngeal margin].
    Janot F; Laccourreye H; Bassot V; Brasnu D; Ménard M; Fabre A
    Ann Otolaryngol Chir Cervicofac; 1988; 105(6):415-21. PubMed ID: 2462399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experiences with intratumor application of bleomycin-oil suspension (BOS) in cancers of the mouth, oropharynx and maxillary sinus].
    Mika H
    HNO; 1982 Dec; 30(12):457-61. PubMed ID: 6186651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
    Ervin TJ; Weichselbaum R; Miller D; Meshad M; Posner M; Fabian R
    Cancer Treat Rep; 1981; 65(9-10):787-91. PubMed ID: 6168371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.